PDE4A and central nervous system cancer: Additionally, PDE4 inhibitor not only directly inhibits the proliferation of glioma cells (54), but also combination with first-line therapy for malignant gliomas (such as temozolomide), enhances the survival rate of mice with intracranial implants of U87 glioblastoma cells (53).